Search results
Viking Therapeutics COO sells shares worth over $22 million By Investing.com
Investing.com· 1 day agoMarianna Mancini, the Chief Operating Officer of Viking Therapeutics, Inc. (NASDAQ:VKTX), has...
Check Out What Whales Are Doing With VKTX - Viking Therapeutics (NASDAQ:VKTX)
Benzinga· 4 days agoLoading... Loading... Whales with a lot of money to spend have taken a noticeably bullish stance on Viking Therapeutics . Looking at options history for Viking Therapeutics VKTX< ...
Q4 2024 Earnings Forecast for Viking Therapeutics, Inc. (NASDAQ:VKTX) Issued By Leerink Partnrs
ETF DAILY NEWS· 5 days agoViking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) – Stock analysts at Leerink Partnrs lifted their Q4 2024 EPS estimates for Viking Therapeutics in a report released on ...
Q2 2024 EPS Estimates for Viking Therapeutics, Inc. Lowered by HC Wainwright (NASDAQ:VKTX)
ETF DAILY NEWS· 4 days agoViking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) – Analysts at HC Wainwright cut their Q2 2024 earnings estimates for Viking Therapeutics in a research report issued ...
Brokers Issue Forecasts for Viking Therapeutics, Inc.’s Q2 2024 Earnings (NASDAQ:VKTX)
ETF DAILY NEWS· 4 days agoViking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) – Stock analysts at William Blair increased their Q2 2024 EPS estimates for Viking Therapeutics in a research report ...
Can This High-Flying Stock 10x in 10 Years?
Motley Fool via Yahoo Finance· 6 days agoViking Therapeutics (NASDAQ: VKTX) has been flying on all cylinders since the beginning of the year. The company's shares are up 246% due to excellent...
Is Viking Therapeutics Incredibly Undervalued?
Motley Fool via Yahoo Finance· 6 days agoViking Therapeutics (NASDAQ: VKTX) has emerged as a beacon of hope in an otherwise lackluster year for healthcare stocks. The buzz around its mid-stage...
Amgen jumps after teasing weight-loss drug data, rival stocks fall
Reuters· 15 hours ago, opens new tab fell 2.3%. , opens new tab is conducting mid-stage studies of the injectable drug...
Oppenheimer reiterates Viking Therapeutics Inc
Knox Daily· 3 days agoAs a result of the transaction, Rouan Sarah Kathryn now holds 0 shares, worth roughly $0.0. Oppenheimer reiterated its Viking Therapeutics Inc [VKTX] rating to an Outperform ...
What Is the Best Weight Loss Stock to Buy Now? Our Top 3 Picks
InvestorPlace· 1 day agoAccording to Harvard University, about two-thirds of United States adults are “overweight or obese,”...
